Anaïs Certain defended her professional degree of Bio-industries and Biotechnologies at University Paris-Saclay in 2016.
She joined the Transcriptomics Platform of the Paris Transplant Group in 2021 to develop new molecular pathology techniques for solid organ transplantation.